Genome-Wide Methylation Mapping Using Nanopore Sequencing Technology Identifies Novel Tumor Suppressor Genes in

Colin F Davenport1, Tobias Scheithauer1, Alessia Dunst2

  • 1Research Core Unit Genomics OE 9415, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30623 Hannover, Germany.

Insights

Glucokinase (GCK) acts as a tumor suppressor gene in hepatocellular carcinoma (HCC). Its overexpression inhibits cancer cell proliferation by depleting cellular energy resources, offering new insights into cancer development.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Tumor suppressor genes (TSGs) downregulation is critical in cancer formation.
  • Epigenetic modifications, including DNA methylation, are implicated in cancer progression and TSG silencing.
  • Hepatocellular carcinoma (HCC) provides a model system to study these mechanisms.

Purpose of the Study:

  • To identify novel tumor suppressor genes (TSGs) in hepatocellular carcinoma (HCC) using genome-wide epigenetic profiling.
  • To functionally characterize the role of glucokinase (GCK) as a potential TSG in HCC.

Main Methods:

  • Genome-wide 5-methylcytosine mapping using nanopore sequencing technology.
  • Integration of methylation data with gene transcription profiles from regenerated liver and primary HCC tissues.
  • Functional characterization of glucokinase (GCK) in HCC cell lines.

Main Results:

  • Identified 10 potential TSG candidates by integrating methylation and transcription data.
  • Demonstrated that glucokinase (GCK) overexpression inhibits HCC cell proliferation.
  • Showed GCK overexpression induces intracellular lactate accumulation, leading to NAD+ depletion and energy crisis.

Conclusions:

  • Glucokinase (GCK) functions as a tumor suppressor gene in HCC.
  • GCK's mechanism involves inducing an energy crisis through lactate accumulation and NAD+ depletion.
  • These findings offer valuable insights into tumorigenesis in human cancers, particularly HCC.